Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats

Planta Medica

Volumn 68, Issue 12, 2002, Pages 1103-1107

  Maki, Toshiyuki ^a   Kawahara, Yuji ^a   Tanonaka, Kouichi ^a   Yagi, Akira ^b   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Collagen; Culture; Fibroblasts; Hypertrophy; Lamiaceae; Myocytes; Salvia miltiorrhiza; Tanshinone VI

Indexed keywords

BOVINE SERUM ALBUMIN; DITERPENE; ENDOTHELIN 1; HUMORAL ANTIBODY; LEUCINE; PHENYLEPHRINE; SOMATOMEDIN; TANSHINONE; TANSHINONE VI; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; MALE; NEWBORN; NONHUMAN; PROTEIN CONTENT; PROTEIN SYNTHESIS; RAT; SALVIA MILTIORRHIZA;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; COLLAGEN; ENDOTHELIN-1; FEMALE; FIBROBLASTS; FIBROSIS; INSULIN-LIKE GROWTH FACTOR I; LEUCINE; MALE; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PHENANTHRENES; PHENYLEPHRINE; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; SALVIA MILTIORRHIZA; TRITIUM;

ANIMALIA; BOVINAE; LAMIACEAE; SALVIA; SALVIA MILTIORRHIZA;

EID: 0036971866     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36337     Document Type: Article

References (18)

1. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000; 35: 19-24
2. Yoshida H, Takahashi M, Tanonaka K, Maki T, Nasa Y, Takeo S. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure. Br J Pharmacol 2001; 134: 150-60
3. Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van-Bilsen M, O'Brien TX, Evans SM. Transcriptional regulation during cardiac growth and development. Ann Rev Physiol 1993; 55: 77-95
4. Huang X, Yang B, Huang H, Xu Y, Hu Z. Studies on the active principles of Dan-Shen III. Search for plant resources containing tanshinone II-A. Chih Wu Hsueh 1980; 22: 98-100
5. Chen Z. Chinese traditional medicines. Some recent studies of Chinese medical plants. Kagaku no Ryoiki 1981; 35: 494-501
6. Takeo S, Tanonaka K, Hirai K, Kawaguchi K, Ogawa M, Yagi A, Fujimoto K. Beneficial effect of tan-shen, an extract from the root of Salvia, on post-hypoxic recovery of cardiac contractile force. Biochem Pharmacol 1990; 40: 1137-43
7. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997; 96: 3737-44
8. Kuwahara K, Saito Y, Harada M, Ishikawa M, Ogawa E, Miyamoto Y, Hamanaka I, Kamitani S, Kajiyama N, Takahashi N, Nakagawa O, Masuda I, Nakao K. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 1999; 100: 1116-24
9. Maki T, Horio T, Yoshihara F, Tokudome T, Suga S, Kawano Y, Takeo S, Kangawa K. Endogenous insulin-like growth factor-1 promotes collagen production and myocyte hypertrophy in an autocrine and paracrine manner in cultured neonatal rat cardiac fibroblasts and myocytes. Circulation 2001; 104: II-186
10. Yagi A, Fujimoto K, Tanonaka K, Hirai K, Takeo S. Possible active components of Tan-Shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements. Planta Med 1989; 55: 51-4
11. Okamura N, Kobayashi K, Yagi A, Kitazawa T, Shimomura K. High-performance liquid chromatography of abietane-type compounds. J Chromatogr 1991; 542: 317-26
12. Maki T, Horio T, Yoshihara F, Suga S, Takeo S, Matsuo H, Kangawa K. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. Br J Pharmacol 2000; 131: 1204-10
13. Ebensperger R, Acevedo E, Melendez J, Corbalan R, Acevedo M, Sapag-Hagar M, Jalil JE, Lavandero S. Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy. Biochem Biophys Res Commun 1998; 243: 20-4
14. Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 1997; 96: 1976-82
15. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000; 35: S1-7
16. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996; 384: 353-5
17. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994; 89: 799-809
18. Maki T, Nasa Y, Yamaguchi F, Yoshida H, Mori M, Takada T, Horikawa E, Okano K, Takeo S. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure. Cardiovasc Res 2001; 51: 608-17